LeaderPortfolio
Yakunin
Vadim Yakunin
Rank #2043
RUSSIAHealthcarePharmacy

Vadim Yakunin

Net Worth
$2.036B
0% (24h)
Vadim Yakunin, born January 5, 1963, is a prominent Russian businessman with a net worth estimated at $2.0 billion as of March 2024. His wealth stems primarily from his involvement in the pharmacy industry. Yakunin is the Chairman of the Board of Directors of Protek-SVM, a major player in the distribution and production of pharmaceuticals and the Rigla pharmacy chain. His career includes a background in the Hungarian tourism sector and founding the Rigla pharmacy chain and Protek. His achievements include building Rigla into a leading pharmacy chain in Russia. Yakunin has a Ph.D. from the Moscow Institute of Physics and Technology.

The Full Dossier

Early Life

Vadim Yakunin was born on January 5, 1963, in the Yaroslavl Region, Russia. He graduated from the Moscow Institute of Physics and Technology (MIPT) in 1986 with a degree in engineer-physicist and completed his postgraduate studies there in 1989.

Rise to Success

Yakunin's career began in the Hungarian tourism sector, gaining experience and insights into the business world. He then transitioned to the pharmaceutical industry, founding the Rigla pharmacy chain, which became a significant player in the Russian market. Yakunin's entrepreneurial spirit led him to establish Protek pharmaceuticals firm, further solidifying his position in the industry. He served as General Director of CJSC CV PROTEK from 1990-2000 and as Chairman of the Board of Directors of CJSC PROTEK from 1998-2002. Since 2002, he has been the Chairman of the Board of Directors of OJSC PROTEK. In 2024, he purchased 70% of a cancer laboratory from Atlas Holding.

Key Business Strategies

Yakunin's primary business ventures include the distribution and production of medicinal products. His main assets are concentrated in CJSC CV PROTEK, JSC PROTEK, and the Rigla Pharmacy Chain.

Philanthropy

Vadim Yakunin founded the Foundation named after St. Gregory the Theologian in 2009.

Career Timeline

2024

Purchased 70% stake in Oncoatlas molecular oncology center

Expanded into the cancer diagnostics field.

2001

Launch of the retail business

Opening of the first pharmacy of the Rigla network.

2002-Present

Chairman of the Board of Directors of OJSC PROTEK

Continues to lead the company, focusing on pharmaceutical distribution and production.

1998-2002

Chairman of the Board of Directors of CJSC PROTEK

Oversaw the strategic direction of the company.

1990-2000

General Director of CJSC CV PROTEK

Led the company's operations and growth.

1990

Founded Protek Center of Implementation

Established a company focused on import and distribution of pharmaceuticals.

Philanthropic Impact

EducationUndisclosed

Foundation named after St. Gregory the Theologian

Founded the foundation in 2009 for implementation of education and educational projects, the development of spiritual formation and church scholarship, and support of educational institutions.

Wealth Trajectory